 | Optimising collection for metabonomic profiling of ejaculate to complement PCR in prostate cancer detection, 2013 - 2013
Funded by: Royal Brisbane and Women's Hospital |
| Optimising prostate cancer detection by molecular and metabonomic analysis of ejaculate, 2012 - 2012
Funded by: Royal Brisbane and Women's Hospital |
| Urinary continence and incontinence in men: New insight through new technologies, 2011 - 2014
Funded by: Australian Research Council, University Of Queensland, GE Healthcare, Mungovan, Breckenridge Physiotherapy and Associates |
| Towards Concurrent Imaging of Primary & Secondary Prostate Cancers, 2010 - 2011
Funded by: Royal Brisbane & Women'S Hospital Foundation |
| A Randomised Trial of Robotic and Open Prostatectomy: Integrates Multidisciplinary Studies to Guide Patient Management - a Partnership of Cancer Council Queensland and the University of Queensland, 2009 - 2013
Funded by: Cancer Council Queensland |
| Prostate Cancer detection employing novel PCA3 isoforms - Bruce Pearson Fellowship 2008, 2009 - 2009
Funded by: Australian Urological Foundation |
| Molecular profiling for prostate cancer prognosis, 2008 - 2009
Funded by: Royal Brisbane & Women'S Hospital Foundation |
| Improved markers for prostate cancer detection, 2008 - 2008
Funded by: Australasian Urology Foundation |
| Prostate Cancer markers of progression and metastasis - Bruce Pearson Fellowship 2006, 2006 - 2006
Funded by: Australasian Urology Foundation |
| Evaluation of two doses of SR31747A (75mg and 125mg) in non-metastatic androgen-independant prostate cancer. Randomized, double-blind, pacebo controlled Phase II Study. (Odyssey Study), 2005 - 2007
Funded by: Sanofi - Synthelabo Australia Pty Ltd |
| Multiple Molecular Markers for Prostate Cancer Diagnosis from Enriched Cells from Ejaculate, 2005 - 2007
Funded by: Queensland Cancer Fund |
| Prostate cell retrieval from ejaculate in prostate cancer diagnosis - Bruce Pearson Fellowship, 2005 - 2005
Funded by: Australasian Urology Foundation |
| A novel one-step approach in the early diagnosis of prostate cancer., 2004 - 2006
Funded by: National Health and Medical Research Council |
| Development of a Novel, Non-Invasive Diagnostic Test For Prostate Cancer, 2004 - 2007
Funded by: United States Of America Department Of Defense |
| REDUCE Study. Protocol ARI40006, 2004 - 2005
Funded by: Glaxo Smith Kline Australia Pty Ltd |
| Analysis of Endothelin- 1 And Its Specific Receptors, A and B In Bladder Tumours, 2004 - 2005
Funded by: University of Queensland |
| Early diagnosis of prostate cancer, 2004 - 2004
Funded by: Royal Brisbane & Women'S Hospital Foundation |
| Molecular Profiling of prostate cells in ejaculate, 2004 - 2004
Funded by: Australasian Urology Foundation |
| Transurethral electrical stimulation for the treatment of genuine stress urinary incontinence, 2003 - 2005
Funded by: Department Of Health And Ageing |
| molecular analysis of 8-cantenin and its role in prostate cancer, 2002 - 2003
Funded by: Royal Brisbane & Women'S Hospital Foundation |
| Clinical study with darifenacin and the overactive bladder (urge urinary incontience)., 2002
Funded by: Pfizer Pty Ltd |
| Diagnosis and prediction of the natural history of prostate cancer: use of ejaculate for molecular profiling, 2002 - 2003
Funded by: Queensland Cancer Fund |
| Clinical Studies with darifenacin in the overactive bladder, 2001 - 2004
Funded by: Pfizer Pty Ltd |
| Overactive Bladder Clinical Studies (Protocols 905-CL-015, -018 and -019), 2001
Funded by: PPD Australia Pty Ltd |
| Use of gene profiling to study the behaviour of prostate cancer, 2001 - 2002
Funded by: Royal Brisbane & Women'S Hospital Foundation |
| Page: | 1 2  |
| |
| Select all records |
| |
» Contacts
